The Reliability, Validity and Responsiveness of Two Disease Scores (BPDAI and ABSIS) for Bullous Pemphigoid: Which One to Use?

Authors

  • Asri Wijayanti
  • Cathy Y. Zhao
  • David Boettiger
  • Yi Z. Chiang
  • Norito Ishii
  • Takashi Hashimoto
  • Dedee F. Murrell

DOI:

https://doi.org/10.2340/00015555-2473

Keywords:

Bullous pemphigoid, outcome measures, BPDAI, ABSIS, ABQOL, TABQOL, validation, responsiveness, MCID

Abstract

A significant obstacle in guiding evidence-based management of bullous pemphigoid (BP) is the lack of a standardised, validated scoring system for the condition. The aim of this study is to evaluate the suitability of the Bullous Pemphigoid Disease Area Index (BPDAI) and the Autoimmune Bullous Skin disorder Intensity Score (ABSIS) as outcome measures for BP in clinical trials. Thirty-two BP patients were repeatedly assessed over four years using Physician Global Assessment (PGA), anti-BP180 ELISA titres, BPDAI, ABSIS, BPDAI-Pruritus, Autoimmune Bullous Disease Quality of Life (ABQOL) and Treatment of Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires. The reliability, validity, responsiveness, and minimal clinically important differences (MCIDs) were calculated. For inter-rater reliability, the intraclass correlation coefficients (95% CI) were: BPDAI 0.957 (0.901?0.982) and ABSIS 0.881 (0.736?0.949). Compared to ABSIS, BPDAI was better correlated with PGA(r=0.875, p<0.001), BPDAI-Pruritus (r=0.632, p=0.004), ABQOL (r=0.521, p=0.011) and TABQOL (r=0.538, p=0.008). MCIDs for BPDAI were 4-points for assessing clinical improvement and 3-points for deterioration. ABSIS demonstrated less responsiveness with MCIDs at 8.6-points for improvement and 4-points for deterioration. These results indicate that BPDAI demonstrated excellent reliability, validity and responsiveness, while ABSIS had moderate to good reliability, validity and responsiveness.

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2016-06-15

How to Cite

Wijayanti, A., Zhao, C. Y., Boettiger, D., Chiang, Y. Z., Ishii, N., Hashimoto, T., & Murrell, D. F. (2016). The Reliability, Validity and Responsiveness of Two Disease Scores (BPDAI and ABSIS) for Bullous Pemphigoid: Which One to Use?. Acta Dermato-Venereologica, 97(1), 24–31. https://doi.org/10.2340/00015555-2473

Issue

Section

Articles